Jaguar Health Launches Neonorm Dog for Pet Digestive Health

Jaguar Health, Inc. is introducing Neonorm Dog, a plant-based product expanding their Neonorm franchise to support canine gut health. Neonorm Dog aims to aid normal stool formation and hydration in dogs, aligning with Jaguar's focus on plant-derived gastrointestinal solutions.

Jaguar Health's existing Neonorm line, including Neonorm Foal and Neonorm Calf, addresses similar needs in foals and calves through botanical extracts from the Croton lechleri tree. Neonorm Dog extends these benefits to a larger pet market, responding to increasing demand for non-antibiotic solutions.

The launch targets a significant demographic in the U.S. and Europe, enhancing market presence and brand recognition. This follows the success of Jaguar's prescription product Canalevia-CA1 for dogs suffering from chemotherapy-induced diarrhea. Neonorm Dog will be available through selected online and retail channels.